NCT04416061

Brief Summary

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium \& Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff. Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,510

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2020

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

June 1, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

June 1, 2020

Last Update Submit

February 26, 2024

Conditions

COVID

Outcome Measures

Primary Outcomes (1)

  • Proportion of asymptomatic subjects

    Proportion of asymptomatic subjects (%) who underwent COVID 19 test

    1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Secondary Outcomes (2)

  • Proportion of subjects with recent contact history

    1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

  • Proportion of subjects with recent travel history

    1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Study Arms (1)

Subjects underwent COVID-19 test

Subjects who underwent COVID-19 test in HKSH during the study period

Diagnostic Test: COVID 19 Diagnostic Test

Interventions

COVID 19 Diagnostic TestDIAGNOSTIC_TEST

COVID 19 Diagnostic Test

Subjects underwent COVID-19 test

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects who underwent COVID-19 test in HKSH during the study period

You may qualify if:

  • Subjects who underwent COVID-19 test in HKSH during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hong Kong Sanatorium & Hospital

Hong Kong, Hong Kong

Location

Study Officials

  • Jonpaul Sze Tsing Zee, MBChB

    Hong Kong Sanatorium & Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist in Infectious Disease

Study Record Dates

First Submitted

June 1, 2020

First Posted

June 4, 2020

Study Start

May 11, 2020

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations

HK(1)